Ireland
--:--IST
Recruiting Not applicable

Effect of Transcranial Direct Current Stimulation on Risk of Falling in Cerebral Palsy Spastic Hemiplegic Children

NCT06730763 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-12-01
Last updated
2025-02-11

Condition(s) studied

Cerebral Palsy (CP)

Investigational drug(s) / intervention(s)

Transcranial direct current stimulationExercise

Transcranial direct current stimulation: Transcranial direct current stimulation (TDCS) is a non-invasive, painless brain stimulation treatment that uses direct electrical currents to stimulate specific parts of the brain.

Exercise: selected traditional physical therapy program for improve balance and decrease risk of falling

Study summary

The purpose of this study was to determine:

* If there is an effect of transcranial direct current stimulation in improvement the functional balance in CP spastic hemiplegic children.
* If there are any changes in risk of falling in CP spastic hemiplegic children or not.

Eligibility

Sex
ALL
Min age
8 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria: * Age range between 8-12 years old. * Classified on levels II and III of the Gross Motor Function Classification System (GMFCS) (Palisiano et al.,1997). * the ability to walk without the assistance of another individual for at least 12 months prior to the onset of the study, regardless of whether a gait-assistance device was needed (GMFCS level III) or not (GMFCS level II). * (Pediatric Balance Scale, Timed Up and Go Test 'TUGT') and acceptance of the TDCS procedure. * Ability to understand and follow simple instructions. * Parent or guardian consent obtained Exclusion Criteria: * Orthopedic deformities, a history of surgery or neurolytic block in the previous 12 months, * Diagnosis of epilepsy or having experienced convulsive crises (whether treated with medication or not) in at least the two years prior to the onset of the study, metal implants in the skull, or the use of hearing aids. * Previous participation in a tDCS study within the past 6 months.

Primary outcome measure(s)

  • The Fall Risk test — From enrollment to the end of treatment at 8 weeks
    The fall risk test allowed identification of potential fall candidates. Test results were compared to age dependent normative data. Scores higher than normative values suggested more fall risk index

Trial sites (1)

FacilityCityRegionStatus
Cairo University Giza Giza Governorate Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06730763 on ClinicalTrials.gov ↗ ← All trials in Egypt